1. Balis FM, Holcenberg JS, Poplack DG (1988) General principles of chemotherapy. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology. J. B. Lippincott, Philadelphia, p 165
2. Clarke L, Waxman DJ (1989) Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Res 49: 2344
3. Edwards G, Calvert RT, Crowther D, Bramwell V, Scarffe H (1980) Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy. Br J Clin Pharmacol 10: 281
4. Erlichman C, Soldin SJ, Hardy RW, Thiessen RW, Sturgeon JFG, Fine S, Baskerville T (1988) Disposition of cyclophosphamide on two consecutive cycles of treatment in patients with ovarian carcinoma. Drug Res 38: 839
5. Faber OK, Mourisden HT, Skovsted L (1974) The biotransformation of cyclophosphamide in man: influence of prednisone. Acta Pharmacol Toxicol 35: 195